PSG.DE PharmaSGP SE XETRA bounces from oversold lows 16 Feb 2026: EUR 30 test

PSG.DE PharmaSGP SE XETRA bounces from oversold lows 16 Feb 2026: EUR 30 test

We see an intraday rebound in PSG.DE stock after a short oversold run, with the share trading at €29.00 on XETRA on 16 Feb 2026. Volume is elevated at 12,424 shares versus an average of 5,399, a 2.30x relative volume signal that buyers stepped in around the day low of €28.60. The bounce aligns with a technical recovery attempt toward the near-term resistance at €30.00, while fundamentals show a modest PE near 17.26 and positive margins. We view this move as an oversold-bounce trade, not a trend reversal, and outline targets, risk points, and Meyka AI model forecasts below.

Continue Reading on Meyka

This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.

Read Full Article →

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *